Search research articles
Contact Us
Filters
Showing results (21-30 of 316) with videos related to
Page
of 32
Sort By:
European Journal of Clinical Investigation
|
May 21, 2009
Minimal diagnostic criteria for myelodysplastic syndromes and separation from ICUS and IDUS: update and open questions
P Valent, H-P Horny
Best Practice & Research. Clinical Haematology
|
June 20, 2006
Pathogenesis, clinical features, and treatment advances in mastocytosis
A Pardanani, C Akin, P Valent
Progress in Growth Factor Research
|
January 1, 1991
The growth and differentiation of mast cells
P Valent, C Sillaber, P Bettelheim
Wiener Klinische Wochenschrift
|
October 13, 1989
[Interleukin-3: a preclinical study]
P Valent, K Geissler, P Bettelheim
International Archives of Allergy and Immunology
|
May 5, 2012
Evaluation of mast cell activation syndromes: impact of pathology and immunohistology
H-P Horny, K Sotlar, P Valent
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
July 10, 2010
Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: a review
H-P Horny, K Sotlar, P Valent
Der Pathologe
|
October 23, 2012
[Mastocytosis and eosinophilic leukemia: diagnostics and classification]
K Sotlar, P Valent, H-P Horny
European Journal of Clinical Investigation
|
January 16, 2007
FIP1L1/PDGFRA is a molecular marker of chronic eosinophilic leukaemia but not for systemic mastocytosis
P Valent, C Akin, D D Metcalfe
The Australian and New Zealand Journal of Psychiatry
|
December 1, 1984
The experience of a mental health team involved in the early phase of a disaster
E F Berah, H J Jones, P Valent
Cancer Genetics and Cytogenetics
|
February 13, 2001
Amplification of the AML1(CBFA2) gene on ring chromosomes in a patient with acute myeloid leukemia and a constitutional ring chromosome 21
B Streubel, P Valent, K Lechner, et al.
Page
of 32
Search research articles
Search
Showing results (21-30 of 316) with videos related to
Sort By:
Page
of 32
European Journal of Clinical Investigation
|
May 21, 2009
Minimal diagnostic criteria for myelodysplastic syndromes and separation from ICUS and IDUS: update and open questions
P Valent, H-P Horny
Best Practice & Research. Clinical Haematology
|
June 20, 2006
Pathogenesis, clinical features, and treatment advances in mastocytosis
A Pardanani, C Akin, P Valent
Progress in Growth Factor Research
|
January 1, 1991
The growth and differentiation of mast cells
P Valent, C Sillaber, P Bettelheim
Wiener Klinische Wochenschrift
|
October 13, 1989
[Interleukin-3: a preclinical study]
P Valent, K Geissler, P Bettelheim
International Archives of Allergy and Immunology
|
May 5, 2012
Evaluation of mast cell activation syndromes: impact of pathology and immunohistology
H-P Horny, K Sotlar, P Valent
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
July 10, 2010
Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: a review
H-P Horny, K Sotlar, P Valent
Der Pathologe
|
October 23, 2012
[Mastocytosis and eosinophilic leukemia: diagnostics and classification]
K Sotlar, P Valent, H-P Horny
European Journal of Clinical Investigation
|
January 16, 2007
FIP1L1/PDGFRA is a molecular marker of chronic eosinophilic leukaemia but not for systemic mastocytosis
P Valent, C Akin, D D Metcalfe
The Australian and New Zealand Journal of Psychiatry
|
December 1, 1984
The experience of a mental health team involved in the early phase of a disaster
E F Berah, H J Jones, P Valent
Cancer Genetics and Cytogenetics
|
February 13, 2001
Amplification of the AML1(CBFA2) gene on ring chromosomes in a patient with acute myeloid leukemia and a constitutional ring chromosome 21
B Streubel, P Valent, K Lechner, et al.
Page
of 32